Neratinib
About
Therapy type: Targeted therapy
Therapy strategy: HER2 inhibition
Mappings
NCI Thesaurus: Neratinib (coding:ncit:C49094)
RxNorm: neratinib (coding:rxcui:1940643, coding:omop:793846)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (2) | HER2-positive | Invasive Breast Carcinoma | Neratinib | |
| FDA (2) HC (1) | HER2-positive | Invasive Breast Carcinoma | Capecitabine, Neratinib | |
| HC (1) | ER positive, HER2-positive, PR positive | Invasive Breast Carcinoma | Neratinib | |
| HC (1) | ER positive, HER2-positive | Invasive Breast Carcinoma | Neratinib | |
| HC (1) | HER2-positive, PR positive | Invasive Breast Carcinoma | Neratinib |